[1] 欧阳学农.癌症疼痛治疗概况[J].福州总医院学报,2010,17(4):258-260. [2] GE F, LIU J, QIU H, et al. Studies on clinical efficacy and safety of morphine sulfate suppositories in treatment of moderate to severe cancer pain[J]. Adverse Drug React J, 2009,11(2): 77-81. [3] Wiffen P J, McQuay H J. Oral morphine for cancer pain[J]. Cochrane Database Syst Rev,2007,4(4):CD003868. [4] 贾晓琳,蒋秋明,董松.硫酸吗啡控释片直肠给药控制晚期癌症疼痛的疗效观察[J].中国现代医药杂志,2006,8(1):12-14. [5] 康马飞,骆梅青,涂江江,等.盐酸吗啡缓释片经直肠给药治疗癌性疼痛的临床研究[J].中国肿瘤临床与康复,2009,16(5):472-474. [6] 贾爱华,韩健,邵军,等.美施康定阴道给药治疗重度癌痛32 例疗效观察[J].中国肿瘤临床,2005,32(1):48-49. [7] 沈惠琴,胡袆,刘忆菁.硫酸吗啡控释片阴道给药治疗女性癌痛的疗效观察[J].解放军护理杂志,2010, 27(1B):94-98. [8] 张志俊,朱保国,王小峰.芬太尼贴剂治疗晚期癌痛的临床疗效分析[J].中国临床研究,2012,25(2):159-160. [9] 丁新梅,赵翌芬.芬太尼贴剂治疗晚期消化道癌痛的临床观察[J].实用诊断与治疗杂志,2008,22(1):55-56. [10] 潘士勇,李宝石,朱小蔚.持续吗啡皮下泵注治疗老年中重度癌痛42例临床分析[J].中华保健医学杂志, 2008,10(2):102-103. [11] 王永辉,柳伟明,李洁,等.大剂量静脉泵入吗啡治疗晚期顽固性癌痛21 例分析[J].中国肿瘤,2008,17(1):77-78. [12] 张谦. 晚期癌痛患者持续静脉泵入吗啡的临床疗效观察[J]. 河北医学,2006, 12(9): 932. [13] 陶蔚, 龚志毅, 王任直.鞘内药物输注系统植入术治疗顽固性疼痛基础医学与临床[J].2006,26(11):1183-1185. [14] 葛峰,仓静,薛张纲.经皮下泵鞘内注射吗啡在晚期癌痛治疗中的安全性和有效性[J].上海医学,2007,30(6):422-424. [15] Elsner F, Zeppetella G, Porta-Sales J, et al.Newer generation fentanyl transmucosal products for breakthrough pain in opioid-tolerant cancer patients[J]. Clin Drug Investig,2011,31(9):605-618. [16] 于世英. 芬太尼新剂型 [J]. 实用医院临床杂志, 2006, 5(3):94-95. [17] Mercadante S, Radbruch L, Davies A, et al. A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial[J]. Curr Med Res Opin, 2009,25(11):2805-2815. [18] Dietrich E, Gums J G. Intranasal fentanyl spray: a novel dosage form for the treatment of breakthrough cancer pain. Ann Pharma-cother[J].2012,46(10):1382-1391. [19] 黄鸣秋,张海霞,葛卫红.癌症患者爆发痛的药物治疗进展[J].中国药房, 2012, 23 (26) :2479-2481. [20] Portenoy R, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain[J]. Pain, 1999, 81(1-2):129-134. [21] Taylor D R. Single-dose fentanyl sublingual spray for breakthrough cancer pain[J]. Clin Pharmacol, 2013,24(5):131-41. [22] Parikh N, Goskonda V, Chavan A, et al. Pharmacokinetics and dose proportionality of fentanyl sublingual spray: a single-dose 5-way crossover study[J]. Clin Drug Investig,2013,33(6):391-400. [23] 朱维莉,时杰,陆林. 芬太尼口腔泡腾片的临床研究进展[J].中国药物依赖性杂志, 2008, 17(4): 245-247. |